Mild Laxatives Market– The Biggest Trends to Watch out for 2021 to 2031Posted by sachi kaushik on March 17th, 2021 The global demand for mild laxatives witnessed a slight fall in the beginning of 2020 due to the spread of Covid-19 pandemic. However in the fourth quarter of the year, the demand started rising again on account of relaxations in stringent regulations. Currently in 2021, leading manufacturers are focusing on innovative launches to create significant attraction among global users. To remain ‘ahead’ of your competitors, request for a sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=964 Eminent vendors like Bayer AG, Boehringer Ingelheim Pharmaceuticals, Procter & Gamble Company, Abbott Laboratories, Takeda Pharmaceuticals and AstraZeneca PLC are undertaking joint ventures, strategic alliances, research & developments, collaborations, mergers & acquisitions, new product launches, product upgradations etc as their main strategies to improve their presence. Segmentation Tentatively, the market can be segmented on the basis of product type, distribution channel and geography. Based on product type, the market is segmented as:
Based on distribution channel, the market is segmented as:
Overview The global market is expected to witness moderate growth over the forecast period. Majority of the laxatives are introduced in the generic market and thus, there exists high competition among local and regional players. Among the product types, the bulk-forming laxatives are expected to lead in the market over the forecast period. The Retail pharmacy distribution channel is expected to contribute high share in the market as it is the most accessible channel and the majority of patients are recommended for outpatient treatment. Regional Outlook Geographically, the global market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant market in the market owing to the high prevalence of constipation. Constipation is the most common digestive complication in the United States. The market in the Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the expansion of the product offerings by the key players. Europe is expected to hold the second large share in the global market throughout the forecast period owing to growing awareness regarding health-related problems. Key Players Some of the key players operating in the market are Bayer AG, GlaxoSmithKline Plc., Procter & Gamble Company, Abbott Laboratories, C. H. Boehringer Sohn AG & Co. KG, Sebela Pharmaceuticals, Inc., Purdue Pharma L.P., Takeda Pharmaceutical Company Ltd among others. The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The report covers exhaustive analysis on:
Regional analysis includes
Drivers and Restraints The growing prevalence and recurrence of constipation is expected to be the major factor driving demand for mild laxatives over the forecast period. Inactive lifestyle and unhealthy eating habits, irregular eating timings, lack of exercise and fewer sleep hours can be held responsible for the growing prevalence of constipation. Obesity is also a major factor responsible for increasing constipation problems. Rising obesity cases make another reason for the growth of the mild laxative market. Mild laxatives are safe to use for pregnant women and kids, which will create more growth opportunities for the players. Over the counter product availability in the market will be a major factor expected to drive the mild laxatives market. The high prescription rate of mild laxatives for primary constipation treatment is expected to boost demand for mild laxatives. Side effects associated with some mild laxatives are some of the factors expected to restrain mild laxatives market. About Us: Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. Contact: US Sales Office: Corporate Headquarter: Like it? Share it! More by this author |